Zalicus (ZLCS) Free Falls on Trade Resumption
Tweet Send to a FriendGet Alerts ZLCS Hot Sheet
Up)
Trade ZLCS Now!
Zalicus Inc. (Nasdaq: ZLCS) has resumed trading and is down 28 percent following phase 2b trial results from Synavive which were statistically significant but missed a key secondary endpoint.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
- InterOil (IOC) Gets Blue Chip 'Stamp of Approval', But Talks Ongoing
- InterOil (IOC) Enters negotiations with ExxonMobil (XOM) on Development Of The Elk And Antelope Resource
Create E-mail Alert Related Categories
FDA, Trader Talk, Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
